Literature DB >> 28596204

Malignant hypertension as a rare cause of thrombotic microangiopathy.

Guramrinder Thind1, Karthik Kailasam1.   

Abstract

Malignant hypertension can occasionally be associated with microangiopathic haemolytic anaemia. A 38-year-old male presented with nausea, vomiting, loss of appetite and oliguria for 2 weeks. He was diagnosed with hypertensive emergency with cardiac and renal dysfunction. Interestingly, further workup was diagnostic for the presence of thrombotic microangiopathy (TMA): haemoglobin =12.7 g/dL, indirect bilirubin =2.0 mg/dL, haptoglobin ≤6 mg/dL, platelet count =121 000/μL and schistocytes on peripheral smear. At the outset, the cause of TMA was unclear. Patient denied having diarrhoea, making haemolytic uremic syndrome less likely. A normal ADAMTS13 activity test ruled out thrombotic thrombocytopaenic purpura. Malignant hypertension induced TMA was highest on the differential and plasma exchange was deferred. Renal biopsy revealed features of TMA and malignant nephrosclerosis. Patient eventually became dialysis dependent. Aggressive blood pressure control was obtained with multiple medications. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Acute renal failure; Hypertension

Mesh:

Substances:

Year:  2017        PMID: 28596204      PMCID: PMC5535052          DOI: 10.1136/bcr-2017-220457

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.

Authors:  Bert-Jan H van den Born; Richard P Koopmans; Gert A van Montfrans
Journal:  Am J Hypertens       Date:  2007-08       Impact factor: 2.689

2.  Microangiopathic hemolysis and renal failure in malignant hypertension.

Authors:  Bert Jan H van den Born; Uwkje P F Honnebier; Richard P Koopmans; Gert A van Montfrans
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

Review 3.  Syndromes of thrombotic microangiopathy.

Authors:  James N George; Carla M Nester
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

4.  Oliguric acute renal failure in malignant hypertension.

Authors:  W D Mattern; S C Sommers; J P Kassirer
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

5.  Nephritic urinary sediment: not only in proliferative glomerulonephritis but also in malignant hypertension.

Authors:  M Moriggi; G Vendramin; M Borghi; G B Fogazzi
Journal:  Nephron       Date:  1995       Impact factor: 2.847

Review 6.  From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.

Authors:  A Cremer; F Amraoui; G Y H Lip; E Morales; S Rubin; J Segura; B J Van den Born; P Gosse
Journal:  J Hum Hypertens       Date:  2015-11-19       Impact factor: 3.012

  6 in total
  3 in total

1.  Thrombotic microangiopathy with multiorgan involvement following COVID-19.

Authors:  Bhavika Gandhi; Deborah Jebakumar; Matthew Nickell; Mohanram Narayanan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-05

2.  A Case of Thrombotic Microangiopathy Secondary to Hypertensive Emergency.

Authors:  Sai Samyuktha Bandaru; Shiva Charan Anaji; Ifeoluwa T Stowe
Journal:  Cureus       Date:  2022-04-18

3.  Thrombotic Microangiopathy Due to Malignant Hypertension Treated Exclusively With Antihypertensive Therapy.

Authors:  Taro Asano; Hideki Mori
Journal:  Cureus       Date:  2022-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.